NCT07019480

Brief Summary

The aim of this prospective, multicenter observational study is to evaluate the influence of various surgical parameters (maximum insertion torque; average insertion torque; final insertion torque; area under the torque curve; intercept and slope of the least squares regression line of the torque curve; implant stability quotient measured immediately after implant insertion) on implant osseointegration and on peri-implant marginal bone loss occurring during the first three months of submerged healing.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
118mo left

Started Jan 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jan 2025Dec 2035

Study Start

First participant enrolled

January 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 5, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 13, 2025

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2031

Expected
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2035

Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

7 years

First QC Date

June 5, 2025

Last Update Submit

June 5, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Implant Stability Quotient (ISQ) for the evaluation of primary stability, measured using a resonance frequency analysis (RFA) device (Osstell).

    Resonance Frequency Analysis (RFA) device (Osstell, Göteborg, Sweden) with the appropriate transducer for the selected abutment (Smartpeg Type 05, Osstell, Göteborg, Sweden). ISQ will be measure in the mesio-distal, disto-mesial, bucco-lingual, and linguo-buccal directions.

    Immediately after implant placement

  • Implant primary stability in Newton

    Insertion torque

    During the full course of implant insertion

  • Periapical radiograph for the assessment of peri-implant bone level (PBL) in millimeters

    Periapical radiograph using a customized Rinn-type film holder for each patient with the aid of a silicone index

    Immediately after implant placement

Secondary Outcomes (7)

  • Implant Stability Quotient (ISQ) for the evaluation of secondary stability, measured using a resonance frequency analysis (RFA) device (Osstell)

    3 months after implant insertion

  • Periapical radiograph for the assessment of peri-implant bone level (PBL) in millimeters

    3 months after implant insertion

  • Periapical radiograph for the assessment of peri-implant bone level (PBL) in millimeters

    upon prosthesis delivery

  • Periapical radiograph for the assessment of peri-implant bone level (PBL) in millimeters

    6 months after prosthetic loading

  • Periapical radiograph for the assessment of peri-implant bone level (PBL) in millimeters

    1 year after prosthetic loading

  • +2 more secondary outcomes

Study Arms (1)

cohort

implant insertion with recorded torque and stability values

Procedure: implant insertion

Interventions

Following local anesthesia (articaine 4% with epinephrine 1:100,000), a minimally invasive full-thickness flap will be elevated. Implant site preparation will be performed with twist drills and the implant will be inserted. Implant stability (ISQ) will be measured in the mesio-distal, disto-mesial, bucco-lingual, and linguo-buccal directions using a resonance frequency analysis device (Osstell Beacon, Osstell, Göteborg, Sweden) with a single-use magnetic peg specific to the implant (SmartPeg Type 07, Osstell, Göteborg, Sweden). The flap will be closed using non-resorbable monofilament sutures, and the implant will be submerged (two-stage protocol).

cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

After investigating general and local anamnesis, which included evaluation of systemic illnesses and potential allergies, a dental visit was conducted to formulate a specific treatment plan. If the patient was deemed eligible for the research protocol, an additional periapical radiograph was obtained for each selected site to assess the adequacy of residual bone height. If the available bone height appeared to be sufficient, a second-level radiographic exam, a Cone Beam Computed Tomography (CBCT), was performed to evaluate whether the bone volume was adequate for supporting implant rehabilitation. For patients requiring tooth extraction, this second assessment was performed after six months of healing after extraction.

You may qualify if:

  • Indication for implant-supported prosthetic rehabilitation of single or multiple partial edentulism in one or both arches, based on accurate diagnosis and treatment planning;
  • The area in which the implants will be placed must have had at least 6 months of healing;
  • Residual alveolar ridge width ≥7 mm;
  • Available bone height \>9 mm at the planned implant site;
  • Patient aged \>18 years;
  • Patient does not use any removable prosthesis at the site to be treated;
  • Patient is able and willing to comply with the study protocol;
  • Patient signs the written informed consent.

You may not qualify if:

  • Acute myocardial infarction within the past two months;
  • Uncontrolled bleeding disorders;
  • Uncontrolled diabetes (HBA1c \> 7.5);
  • History of head and/or neck radiotherapy within the past 24 months;
  • Immunocompromised patients, HIV positive, or undergoing chemotherapy within the past five years;
  • Current or previous antiresorptive therapy;
  • Psychological or psychiatric disorders;
  • Drug or alcohol abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Trieste

Trieste, TS, 34125, Italy

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2025

First Posted

June 13, 2025

Study Start

January 1, 2025

Primary Completion (Estimated)

December 31, 2031

Study Completion (Estimated)

December 31, 2035

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations